Childhood trauma exposure in substance use disorder patients with and without ADHD

Maija Konstenius, Anders Leifman, Katelijne van Emmerik-van Oortmerssen, Geurt van de Glind, Johan Franck, Franz Moggi, Josep Antoni Ramos-Quiroga, Frances R Levin, Pieter Jan Carpentier, Arvid Skutle, Eli-Torild Bu, Sharlene Kaye, Zsolt Demetrovics, Csaba Barta, Marc Auriecomb, Melina Fatséas, Brian Johnson, Stephen V Faraone, Steve Allsop, Susan Carruthers, Robert A Schoevers, Sofie Verspreet, Geert Dom, Maarten W J Koeter, Wim van den Brink
Addictive Behaviors. 2017-02-01; 65: 118-124
DOI: 10.1016/j.addbeh.2016.10.016

PubMed
Read on PubMed



1. Addict Behav. 2017 Feb;65:118-124. doi: 10.1016/j.addbeh.2016.10.016. Epub 2016
Oct 24.

Childhood trauma exposure in substance use disorder patients with and without
ADHD.

Konstenius M(1), Leifman A(2), van Emmerik-van Oortmerssen K(3), van de Glind
G(4), Franck J(5), Moggi F(6), Ramos-Quiroga JA(7), Levin FR(8), Carpentier
PJ(9), Skutle A(10), Bu ET(10), Kaye S(11), Demetrovics Z(12), Barta C(13),
Auriecomb M(14), Fatséas M(14), Johnson B(15), Faraone SV(15), Allsop S(16),
Carruthers S(16), Schoevers RA(17), Verspreet S(18), Dom G(18), Koeter MW(4), van
den Brink W(4).

Author information:
(1)Department of Clinical Neuroscience, Division of Psychiatry, Karolinska
Institutet, Stockholm, Sweden. Electronic address: .
(2)Stockholm Center for Dependency Disorders, Sweden.
(3)Arkin, Amsterdam, The Netherlands; Amsterdam Institute for Addiction Research,
Department of Psychiatry, Academic Medical Center, University of Amsterdam,
Amsterdam, The Netherlands.
(4)Amsterdam Institute for Addiction Research, Department of Psychiatry, Academic
Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
(5)Department of Clinical Neuroscience, Division of Psychiatry, Karolinska
Institutet, Stockholm, Sweden.
(6)University Hospital of Psychiatry, University of Bern, Bern, Switzerland;
Department of Psychology, University of Fribourg, Fribourg, Switzerland.
(7)Servei de Psiquiatria, Hospital Universitari Vall d’Hebron, CIBERSAM,
Department of Psychiatry, Spain.
(8)Columbia University/the New York State Psychiatric Institute, New York, USA.
(9)Reinier van Arkel groep,’s-Hertogenbosch, The Netherlands.
(10)Bergen Clinics Foundation, Bergen, Norway.
(11)National Drug and Alcohol Research Centre, University of New South Wales,
Sydney, Australia.
(12)Institute of Psychology, Eötvös Loránd University, Budapest, Hungary.
(13)Institute of Medical Chemistry, Molecular Biology and Pathobiochemistry,
Semmelweis University, Budapest, Hungary.
(14)Laboratoire de psychiatrie Département d’addictologie, Université de
Bordeaux, France.
(15)Department of Psychiatry, SUNY Upstate Medical University, Syracuse, NY, USA;
Department of Neuroscience and Physiology, SUNY Upstate Medical University,
Syracuse, NY, USA.
(16)National Drug Research Institute, Curtin University of Technology, Perth,
Australia.
(17)Department of Psychiatry, University Medical Center Groningen, University of
Groningen, Groningen, The Netherlands.
(18)Collaborative Antwerp Psychiatry Research Institute (CAPRI, UA), PC Alexian
Brothers, Boechout, Belgium.

DOI: 10.1016/j.addbeh.2016.10.016
PMCID: PMC5518307
PMID: 27816036 [Indexed for MEDLINE]

Know more about